Dyskeratosis congenita and the DNA damage response

Summary Dyskeratosis congenita (DC) is a heterogeneous bone marrow failure disorder with known mutations in components of telomerase and telomere shelterin. Recent work in a mouse model with a dyskerin mutation has implicated an increased DNA damage response as part of the cellular pathology, while...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of haematology 2011-06, Vol.153 (5), p.634-643
Hauptverfasser: Kirwan, Michael, Beswick, Richard, Walne, Amanda J., Hossain, Upal, Casimir, Colin, Vulliamy, Tom, Dokal, Inderjeet
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 643
container_issue 5
container_start_page 634
container_title British journal of haematology
container_volume 153
creator Kirwan, Michael
Beswick, Richard
Walne, Amanda J.
Hossain, Upal
Casimir, Colin
Vulliamy, Tom
Dokal, Inderjeet
description Summary Dyskeratosis congenita (DC) is a heterogeneous bone marrow failure disorder with known mutations in components of telomerase and telomere shelterin. Recent work in a mouse model with a dyskerin mutation has implicated an increased DNA damage response as part of the cellular pathology, while mouse models with Terc and Tert mutations displayed a normal response. To clarify how these contradictory results might apply to DC pathology in humans, we studied the cellular phenotype in primary cells from DC patients of several genetic subtypes, focussing on T lymphocytes to remain close to the haematopoietic system. We observed novel cell cycle abnormalities in conjunction with impaired growth and an increase in apoptosis. Using flow cytometry and confocal microscopy we examined induction of the DNA damage proteins γ‐H2AX and 53BP1 and the cell cycle protein TP53 (p53). We found an increase in damage foci at telomeres in lymphocytes and an increase in the basal level of DNA damage in fibroblasts, but crucially no increased response to DNA damaging agents in either cell type. As the response to induced DNA damage was normal and levels of global DNA damage were inconsistent between cell types, DNA damage may contribute differently to the pathology in different tissues.
doi_str_mv 10.1111/j.1365-2141.2011.08679.x
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3328754</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>904474881</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5699-f2cd2e40b6124aa3b1dad4ab64a83743215eca040c4b59c394800838a0f72ed03</originalsourceid><addsrcrecordid>eNqNkU2P0zAQhi0EYsvCX0C5IMQhYfwRxz6AVHaBgiq4wNmaOJM2JU2KnS7bf09CS_m4gC-2_D7zesYvYwmHjI_r-SbjUuep4IpnAjjPwOjCZrd32Ows3GUzAChSDspcsAcxbgC4hJzfZxejXhQC7IyJ60P8QgGHPjYx8X23oq4ZMMGuSoY1Jdcf5kmFW1xREiju-i7SQ3avxjbSo9N-yT6_ef3papEuP759dzVfpj7X1qa18JUgBaXmQiHKkldYKSy1QiMLJQXPySMo8KrMrZdWGQAjDUJdCKpAXrKXR9_dvtxS5akbArZuF5othoPrsXF_Kl2zdqv-xkkpTJGr0eDZ0WD9V9livnTTHYCWIAy_4SP79PRY6L_uKQ5u20RPbYsd9fvoLChVKGP-TRqtQY3D2ZE0R9KHPsZA9bkJDm7K0W3cFJeb4nJTju5Hju52LH38--znwp_BjcCTE4DRY1sH7HwTf3GKGyv19Acvjty3pqXDfzfgXr1fTCf5Ha9yttU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>866042159</pqid></control><display><type>article</type><title>Dyskeratosis congenita and the DNA damage response</title><source>Wiley Free Content</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Kirwan, Michael ; Beswick, Richard ; Walne, Amanda J. ; Hossain, Upal ; Casimir, Colin ; Vulliamy, Tom ; Dokal, Inderjeet</creator><creatorcontrib>Kirwan, Michael ; Beswick, Richard ; Walne, Amanda J. ; Hossain, Upal ; Casimir, Colin ; Vulliamy, Tom ; Dokal, Inderjeet</creatorcontrib><description>Summary Dyskeratosis congenita (DC) is a heterogeneous bone marrow failure disorder with known mutations in components of telomerase and telomere shelterin. Recent work in a mouse model with a dyskerin mutation has implicated an increased DNA damage response as part of the cellular pathology, while mouse models with Terc and Tert mutations displayed a normal response. To clarify how these contradictory results might apply to DC pathology in humans, we studied the cellular phenotype in primary cells from DC patients of several genetic subtypes, focussing on T lymphocytes to remain close to the haematopoietic system. We observed novel cell cycle abnormalities in conjunction with impaired growth and an increase in apoptosis. Using flow cytometry and confocal microscopy we examined induction of the DNA damage proteins γ‐H2AX and 53BP1 and the cell cycle protein TP53 (p53). We found an increase in damage foci at telomeres in lymphocytes and an increase in the basal level of DNA damage in fibroblasts, but crucially no increased response to DNA damaging agents in either cell type. As the response to induced DNA damage was normal and levels of global DNA damage were inconsistent between cell types, DNA damage may contribute differently to the pathology in different tissues.</description><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/j.1365-2141.2011.08679.x</identifier><identifier>PMID: 21477209</identifier><identifier>CODEN: BJHEAL</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adolescent ; Adult ; Apoptosis - genetics ; Biological and medical sciences ; cell cycle ; Cell Cycle - genetics ; Child, Preschool ; Dermatology ; DNA Damage ; dyskeratosis congenita ; Dyskeratosis Congenita - genetics ; Dyskeratosis Congenita - immunology ; Dyskeratosis Congenita - metabolism ; Female ; Fibroblasts - metabolism ; Hematologic and hematopoietic diseases ; Histones - metabolism ; Humans ; Intracellular Signaling Peptides and Proteins - metabolism ; lymphocytes ; Male ; Medical sciences ; Microscopy, Confocal ; Paediatric ; Pigmentary diseases of the skin ; T-Lymphocytes - metabolism ; T-Lymphocytes - pathology ; Telomere - genetics ; telomeres ; Tissue Culture Techniques ; Tumor Suppressor p53-Binding Protein 1 ; Tumor Suppressor Protein p53 - metabolism ; Up-Regulation - genetics ; Young Adult</subject><ispartof>British journal of haematology, 2011-06, Vol.153 (5), p.634-643</ispartof><rights>2011 Blackwell Publishing Ltd</rights><rights>2015 INIST-CNRS</rights><rights>2011 Blackwell Publishing Ltd.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>2011 Blackwell Publishing Ltd 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5699-f2cd2e40b6124aa3b1dad4ab64a83743215eca040c4b59c394800838a0f72ed03</citedby><cites>FETCH-LOGICAL-c5699-f2cd2e40b6124aa3b1dad4ab64a83743215eca040c4b59c394800838a0f72ed03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2141.2011.08679.x$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2141.2011.08679.x$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=24189364$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21477209$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-00630281$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Kirwan, Michael</creatorcontrib><creatorcontrib>Beswick, Richard</creatorcontrib><creatorcontrib>Walne, Amanda J.</creatorcontrib><creatorcontrib>Hossain, Upal</creatorcontrib><creatorcontrib>Casimir, Colin</creatorcontrib><creatorcontrib>Vulliamy, Tom</creatorcontrib><creatorcontrib>Dokal, Inderjeet</creatorcontrib><title>Dyskeratosis congenita and the DNA damage response</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><description>Summary Dyskeratosis congenita (DC) is a heterogeneous bone marrow failure disorder with known mutations in components of telomerase and telomere shelterin. Recent work in a mouse model with a dyskerin mutation has implicated an increased DNA damage response as part of the cellular pathology, while mouse models with Terc and Tert mutations displayed a normal response. To clarify how these contradictory results might apply to DC pathology in humans, we studied the cellular phenotype in primary cells from DC patients of several genetic subtypes, focussing on T lymphocytes to remain close to the haematopoietic system. We observed novel cell cycle abnormalities in conjunction with impaired growth and an increase in apoptosis. Using flow cytometry and confocal microscopy we examined induction of the DNA damage proteins γ‐H2AX and 53BP1 and the cell cycle protein TP53 (p53). We found an increase in damage foci at telomeres in lymphocytes and an increase in the basal level of DNA damage in fibroblasts, but crucially no increased response to DNA damaging agents in either cell type. As the response to induced DNA damage was normal and levels of global DNA damage were inconsistent between cell types, DNA damage may contribute differently to the pathology in different tissues.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Apoptosis - genetics</subject><subject>Biological and medical sciences</subject><subject>cell cycle</subject><subject>Cell Cycle - genetics</subject><subject>Child, Preschool</subject><subject>Dermatology</subject><subject>DNA Damage</subject><subject>dyskeratosis congenita</subject><subject>Dyskeratosis Congenita - genetics</subject><subject>Dyskeratosis Congenita - immunology</subject><subject>Dyskeratosis Congenita - metabolism</subject><subject>Female</subject><subject>Fibroblasts - metabolism</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Histones - metabolism</subject><subject>Humans</subject><subject>Intracellular Signaling Peptides and Proteins - metabolism</subject><subject>lymphocytes</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Microscopy, Confocal</subject><subject>Paediatric</subject><subject>Pigmentary diseases of the skin</subject><subject>T-Lymphocytes - metabolism</subject><subject>T-Lymphocytes - pathology</subject><subject>Telomere - genetics</subject><subject>telomeres</subject><subject>Tissue Culture Techniques</subject><subject>Tumor Suppressor p53-Binding Protein 1</subject><subject>Tumor Suppressor Protein p53 - metabolism</subject><subject>Up-Regulation - genetics</subject><subject>Young Adult</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><recordid>eNqNkU2P0zAQhi0EYsvCX0C5IMQhYfwRxz6AVHaBgiq4wNmaOJM2JU2KnS7bf09CS_m4gC-2_D7zesYvYwmHjI_r-SbjUuep4IpnAjjPwOjCZrd32Ows3GUzAChSDspcsAcxbgC4hJzfZxejXhQC7IyJ60P8QgGHPjYx8X23oq4ZMMGuSoY1Jdcf5kmFW1xREiju-i7SQ3avxjbSo9N-yT6_ef3papEuP759dzVfpj7X1qa18JUgBaXmQiHKkldYKSy1QiMLJQXPySMo8KrMrZdWGQAjDUJdCKpAXrKXR9_dvtxS5akbArZuF5othoPrsXF_Kl2zdqv-xkkpTJGr0eDZ0WD9V9livnTTHYCWIAy_4SP79PRY6L_uKQ5u20RPbYsd9fvoLChVKGP-TRqtQY3D2ZE0R9KHPsZA9bkJDm7K0W3cFJeb4nJTju5Hju52LH38--znwp_BjcCTE4DRY1sH7HwTf3GKGyv19Acvjty3pqXDfzfgXr1fTCf5Ha9yttU</recordid><startdate>201106</startdate><enddate>201106</enddate><creator>Kirwan, Michael</creator><creator>Beswick, Richard</creator><creator>Walne, Amanda J.</creator><creator>Hossain, Upal</creator><creator>Casimir, Colin</creator><creator>Vulliamy, Tom</creator><creator>Dokal, Inderjeet</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><general>Wiley</general><scope>24P</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>7TM</scope><scope>H94</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope></search><sort><creationdate>201106</creationdate><title>Dyskeratosis congenita and the DNA damage response</title><author>Kirwan, Michael ; Beswick, Richard ; Walne, Amanda J. ; Hossain, Upal ; Casimir, Colin ; Vulliamy, Tom ; Dokal, Inderjeet</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5699-f2cd2e40b6124aa3b1dad4ab64a83743215eca040c4b59c394800838a0f72ed03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Apoptosis - genetics</topic><topic>Biological and medical sciences</topic><topic>cell cycle</topic><topic>Cell Cycle - genetics</topic><topic>Child, Preschool</topic><topic>Dermatology</topic><topic>DNA Damage</topic><topic>dyskeratosis congenita</topic><topic>Dyskeratosis Congenita - genetics</topic><topic>Dyskeratosis Congenita - immunology</topic><topic>Dyskeratosis Congenita - metabolism</topic><topic>Female</topic><topic>Fibroblasts - metabolism</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Histones - metabolism</topic><topic>Humans</topic><topic>Intracellular Signaling Peptides and Proteins - metabolism</topic><topic>lymphocytes</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Microscopy, Confocal</topic><topic>Paediatric</topic><topic>Pigmentary diseases of the skin</topic><topic>T-Lymphocytes - metabolism</topic><topic>T-Lymphocytes - pathology</topic><topic>Telomere - genetics</topic><topic>telomeres</topic><topic>Tissue Culture Techniques</topic><topic>Tumor Suppressor p53-Binding Protein 1</topic><topic>Tumor Suppressor Protein p53 - metabolism</topic><topic>Up-Regulation - genetics</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kirwan, Michael</creatorcontrib><creatorcontrib>Beswick, Richard</creatorcontrib><creatorcontrib>Walne, Amanda J.</creatorcontrib><creatorcontrib>Hossain, Upal</creatorcontrib><creatorcontrib>Casimir, Colin</creatorcontrib><creatorcontrib>Vulliamy, Tom</creatorcontrib><creatorcontrib>Dokal, Inderjeet</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kirwan, Michael</au><au>Beswick, Richard</au><au>Walne, Amanda J.</au><au>Hossain, Upal</au><au>Casimir, Colin</au><au>Vulliamy, Tom</au><au>Dokal, Inderjeet</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dyskeratosis congenita and the DNA damage response</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>2011-06</date><risdate>2011</risdate><volume>153</volume><issue>5</issue><spage>634</spage><epage>643</epage><pages>634-643</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><coden>BJHEAL</coden><abstract>Summary Dyskeratosis congenita (DC) is a heterogeneous bone marrow failure disorder with known mutations in components of telomerase and telomere shelterin. Recent work in a mouse model with a dyskerin mutation has implicated an increased DNA damage response as part of the cellular pathology, while mouse models with Terc and Tert mutations displayed a normal response. To clarify how these contradictory results might apply to DC pathology in humans, we studied the cellular phenotype in primary cells from DC patients of several genetic subtypes, focussing on T lymphocytes to remain close to the haematopoietic system. We observed novel cell cycle abnormalities in conjunction with impaired growth and an increase in apoptosis. Using flow cytometry and confocal microscopy we examined induction of the DNA damage proteins γ‐H2AX and 53BP1 and the cell cycle protein TP53 (p53). We found an increase in damage foci at telomeres in lymphocytes and an increase in the basal level of DNA damage in fibroblasts, but crucially no increased response to DNA damaging agents in either cell type. As the response to induced DNA damage was normal and levels of global DNA damage were inconsistent between cell types, DNA damage may contribute differently to the pathology in different tissues.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>21477209</pmid><doi>10.1111/j.1365-2141.2011.08679.x</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1048
ispartof British journal of haematology, 2011-06, Vol.153 (5), p.634-643
issn 0007-1048
1365-2141
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3328754
source Wiley Free Content; MEDLINE; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals
subjects Adolescent
Adult
Apoptosis - genetics
Biological and medical sciences
cell cycle
Cell Cycle - genetics
Child, Preschool
Dermatology
DNA Damage
dyskeratosis congenita
Dyskeratosis Congenita - genetics
Dyskeratosis Congenita - immunology
Dyskeratosis Congenita - metabolism
Female
Fibroblasts - metabolism
Hematologic and hematopoietic diseases
Histones - metabolism
Humans
Intracellular Signaling Peptides and Proteins - metabolism
lymphocytes
Male
Medical sciences
Microscopy, Confocal
Paediatric
Pigmentary diseases of the skin
T-Lymphocytes - metabolism
T-Lymphocytes - pathology
Telomere - genetics
telomeres
Tissue Culture Techniques
Tumor Suppressor p53-Binding Protein 1
Tumor Suppressor Protein p53 - metabolism
Up-Regulation - genetics
Young Adult
title Dyskeratosis congenita and the DNA damage response
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T17%3A34%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dyskeratosis%20congenita%20and%20the%20DNA%20damage%20response&rft.jtitle=British%20journal%20of%20haematology&rft.au=Kirwan,%20Michael&rft.date=2011-06&rft.volume=153&rft.issue=5&rft.spage=634&rft.epage=643&rft.pages=634-643&rft.issn=0007-1048&rft.eissn=1365-2141&rft.coden=BJHEAL&rft_id=info:doi/10.1111/j.1365-2141.2011.08679.x&rft_dat=%3Cproquest_pubme%3E904474881%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=866042159&rft_id=info:pmid/21477209&rfr_iscdi=true